Researcher
Ramanuj DasGupta joined A*STAR’s Genome Institute of Singapore (GIS) in 2014 where he is now a Senior Group Leader. DasGupta obtained his Ph.D. in Developmental and Stem cell Biology at the University of Chicago followed by postdoctoral studies at the Harvard Medical School. The major focus in the DasGupta laboratory is to explore fundamental mechanisms of cancer evolution and implement “Response-driven Precision Oncology” in the clinic by utilizing next-generation, multi-omic single cell and spatial transcriptomic technologies.
Related Articles
COVID-19’s far-reaching effects from lung to liver
30 Nov 2021Using single-cell sequencing technology, A*STAR scientists have identified a rare population of liver cells susceptible
Tumors hide by mimicking fetal characteristics
26 Apr 2021Liver tumors gain immune tolerance by activating cellular mechanisms involved in fetal development.
Poised for survival
16 Apr 2019State-of-the-art single-cell RNA sequencing technologies shed light on the mechanisms through which cancer cells become